June 28, 2019
by Nobel Biocare
For over 50 years, Nobel Biocare has been a pioneering force for implant dentistry. At the Global Symposium in Madrid, the company is now taking innovation to another level with the announcement of its Nobel Biocare N1™ implant system.
Soon to be available to dental professionals worldwide, the purpose behind the new system was to make treatments faster as well as more straightforward and predictable. To achieve this required challenging conventional techniques in implantology. Addressing some of the shortcomings of current protocols, Nobel Biocare N1 was designed from the ground up with biological principles and patient needs in mind. In collaboration with a group of international researchers and clinicians, Nobel Biocare is now bringing to the market this long-anticipated new system, which was created from over five years of scientific and clinical refinement.
The entire Nobel Biocare N1 system, from planning to the prosthetic delivery, was created to streamline workflows and enhance patient comfort. Going beyond a new implant design, Nobel Biocare is also redefining site preparation with the introduction of the OsseoShaper ™, a new innovative alternative to conventional drilling protocols. Experience gained from over 18 months of clinical evaluations with an early ambassador group on the Nobel Biocare N1 concept have already indicated promising results in terms of the method’s effectiveness.
Fully embracing the new Mucointegration™ concept, the Xeal™ and TiUltra™ surfaces will be available on the Nobel Biocare N1 implant system from day one. With the help of their specially tailored surface chemistry and topography, the Nobel Biocare N1 TiUltra implants and Xeal abutments can thus benefit from optimized tissue integration.
Nobel Biocare N1 will be further integrated into the digital workflow with DTX Studio™, giving dental professionals more opportunities to provide patients with shorter-time-teeth.
“Our Nobel Biocare N1 system is a real breakthrough in almost every aspect of the treatment workflow,” said Nobel Biocare President Hans Geiselhöringer. “With the help of our early ambassador group we have collected over 18 months of clinical experience on the Nobel Biocare N1 concept as well as the unique implant site preparation technique. The feedback we received from clinicians experiencing the system for the first time here in Madrid has been extremely positive. I am more than convinced that the system will be able to set new standards for the industry.”
Dental professionals visiting the Nobel Biocare Global Symposium in Madrid have until Saturday, June 29, to discover and try out the new system. Nobel Biocare N1 will first become available to clinicians in CE markets later in 2019, followed by additional markets pending regulatory approval.
More information about Nobel Biocare N1™ is also available at www.nobelbiocare.com/n1
About Nobel Biocare
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive® and NobelParallel™ and ceramic implant NobelPearl™*) a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), digital solutions for treatment planning and guided surgery (NobelClinician® and DTX Studio™ suite) as well as biomaterials. Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at four sites located in the United States, Sweden and Japan. Products and services are available in over 80 countries through subsidiaries and distributors.